1-6 of 6
Erica K. Evans
Close
Sort by
Journal Articles

Pure Pathologic Response Is Associated with Improved Overall Survival in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib in the Phase I EXPLORER Study

Jason Gotlib, MD MS, Deepti H. Radia, MRCPI, FRCPath, Tracy I. George, MD, William A Robinson, MD PhD, Albert T. Quiery, MD, Mark W. Drummond, PhD FRCPath, Prithviraj Bose, MD, Elizabeth O. Hexner, MD, Elliott F. Winton, MD, Hans-Peter Horny, Prof, Dr, Meera Tugnait, PhD, Oleg Schmidt-Kittler, PhD, Erica K. Evans, PhD, Hui-Min Lin, PhD, Brenton G. Mar, MD PhD, Michael W. Deininger, MD PhD, Daniel J. DeAngelo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137413
Published: 2020
Journal Articles

Inhibitory Effects of Midostaurin and Blu-285 on Myeloid Progenitor Cells Derived from Patients with Multi-Mutated KIT D816V+ Advanced Systemic Mastocytosis

Mohamad Jawhar, MD, Nicole Naumann, Sebastian Kluger, Juliana Schwaab, MD, Georgia Metzgeroth, MD, Erica K. Evans, PhD, Alexandra Gardino, PhD, Christoph Lengauer, PhD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Alice Fabarius, PhD, Andreas Reiter, MD
Journal: Blood
Blood (2016) 128 (22): 1964.
https://doi.org/10.1182/blood.V128.22.1964.1964
Published: 2016
Journal Articles

Systemic Mastocytosis Patient Experience from Mast Cell Connect, the First Patient-Reported Registry for Mastocytosis

Philina Lee, PhD, Tracy I. George, MD, Hongliang Shi, MS, Erica K. Evans, PhD, Teghpal Singh, PhD, Anthony L Boral, MD PhD, Vanessa Rangel Miller, MS, MBA, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4783.
https://doi.org/10.1182/blood.V128.22.4783.4783
Published: 2016
Journal Articles

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Mark W. Drummond, PhD MD, Daniel J. DeAngelo, MD PhD, Michael W. Deininger, MD PhD, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Albert Thomas Quiery, MD, Elizabeth O Hexner, MD, Hongliang Shi, MS, Terri Alvarez-Diez, PhD, Erica K. Evans, PhD, Mary Ellen Healy, MS, Beni B. Wolf, MD PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 477.
https://doi.org/10.1182/blood.V128.22.477.477
Published: 2016
Journal Articles

First Selective KIT D816V Inhibitor for Patients with Systemic Mastocytosis

Erica K. Evans, PhD, Brian L. Hodous, PhD, Alexandra Gardino, PhD, Julia Zhu, B.S., Adam Shutes, PhD, Alison Davis, PhD, Joseph Kim, PhD, Kevin Wilson, M.S., Doug Wilson, PhD, Yulian Zhang, PhD, Nancy E. Kohl, PhD, Timothy Guzi, PhD, Christoph Lengauer, PhD
Journal: Blood
Blood (2014) 124 (21): 3217.
https://doi.org/10.1182/blood.V124.21.3217.3217
Published: 2014
Journal Articles

The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells

Francesco D'Alo', Lisa M. Johansen, Erik A. Nelson, Hanna S. Radomska, Erica K. Evans, Pu Zhang, Claus Nerlov, Daniel G. Tenen
Journal: Blood
Blood (2003) 102 (9): 3163–3171.
https://doi.org/10.1182/blood-2003-02-0479
Published: 2003